Aclaris Therapeutics Inc (ACRS)
R&D Expenses
$18.85M
Quarterly · Period ending: · USD
ACRS R&D Expenses
Latest reported$18.85Mperiod ending
Latest reported$18.85Mperiod ending
ACRS Quarterly R&D Expenses ($1.18M → $18.85M)
Quarterly R&D Expenses
High-resolution chart · PNG
ACRS r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 18,850,000 | |
| 15,657,000 | |
| 16,584,000 | |
| 13,028,000 | |
| 11,449,000 | |
| 11,584,000 | |
| 9,026,000 | |
| 5,956,000 | |
| 8,759,000 | |
| 9,845,000 | |
| 26,646,000 | |
| 23,876,000 | |
| 25,275,000 | |
| 22,587,000 | |
| 21,072,000 | |
| 23,656,000 | |
| 18,779,000 | |
| 14,306,000 | |
| 14,102,000 | |
| 13,976,000 | |
| 7,897,000 | |
| 7,838,000 | |
| 8,955,000 | |
| 6,240,000 | |
| 6,466,000 | |
| 7,677,000 | |
| 11,565,000 | |
| 16,183,000 | |
| 17,622,000 | |
| 19,919,000 | |
| 19,537,000 | |
| 15,931,000 | |
| 13,984,000 | |
| 13,606,000 | |
| 13,189,000 | |
| 10,864,000 | |
| 7,965,000 | |
| 7,772,000 | |
| 6,943,000 | |
| 7,162,000 | |
| 9,836,000 | |
| 9,535,000 | |
| 2,402,000 | |
| 9,408,000 | |
| 1,793,000 | |
| 1,737,000 | |
| 2,054,000 | |
| 2,097,000 | |
| 1,178,000 | |
| 1,178,000 |